Compare Ascendis Pharma A/S (ASND) vs Carnival Corp (CCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Carnival Corp — how do they compare? Ascendis Pharma A/S trades at $254.01 (market cap $16.67B), while Carnival Corp trades at $27.88 (market cap $37.98B). The key difference: Carnival Corp is far larger — about 2.3× Ascendis Pharma A/S's market cap, and Carnival Corp pays a 1.62% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | CCL | |
|---|---|---|
Market Cap | $16.67B | $37.98B |
Sector | Health | Consumer Cyclical |
52-Week High | $277.18 | $33.99 |
52-Week Low | $189.74 | $23.89 |
Enterprise Value | $17.04B | $61.91B |
Dividend Yield | — | 1.62% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Carnival Corp
Carnival is the largest global cruise company, with 91 ships in its fleet in October 2022, with eight of its nine brands set to be fully redeployed by the end of 2022. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America.
Read more on CCL →
